AMMAZZALORSO, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 7.896
EU - Europa 4.636
AS - Asia 4.510
Continente sconosciuto - Info sul continente non disponibili 712
SA - Sud America 495
AF - Africa 86
OC - Oceania 6
Totale 18.341
Nazione #
US - Stati Uniti d'America 7.606
SG - Singapore 1.669
CN - Cina 1.228
IT - Italia 1.183
TR - Turchia 552
IE - Irlanda 540
UA - Ucraina 486
SE - Svezia 466
RU - Federazione Russa 413
GB - Regno Unito 405
VN - Vietnam 403
BR - Brasile 399
FR - Francia 317
IN - India 299
DE - Germania 266
CA - Canada 170
PL - Polonia 144
FI - Finlandia 138
HK - Hong Kong 71
ES - Italia 61
JP - Giappone 47
BD - Bangladesh 44
LT - Lituania 43
MX - Messico 43
NL - Olanda 35
AT - Austria 34
KR - Corea 31
CZ - Repubblica Ceca 28
ZA - Sudafrica 28
AR - Argentina 26
BE - Belgio 25
PK - Pakistan 24
ID - Indonesia 20
IQ - Iraq 19
VE - Venezuela 17
CR - Costa Rica 16
EC - Ecuador 15
CL - Cile 14
IL - Israele 14
PH - Filippine 14
JM - Giamaica 12
MA - Marocco 12
CO - Colombia 11
DZ - Algeria 11
HN - Honduras 9
TW - Taiwan 9
MY - Malesia 8
PT - Portogallo 8
GR - Grecia 7
GT - Guatemala 7
KE - Kenya 7
SA - Arabia Saudita 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CH - Svizzera 6
ET - Etiopia 6
HR - Croazia 6
JO - Giordania 6
SC - Seychelles 6
SV - El Salvador 6
AL - Albania 5
EG - Egitto 5
IR - Iran 5
NI - Nicaragua 5
PE - Perù 5
AZ - Azerbaigian 4
BG - Bulgaria 4
BH - Bahrain 4
CW - ???statistics.table.value.countryCode.CW??? 4
EE - Estonia 4
NP - Nepal 4
PR - Porto Rico 4
PY - Paraguay 4
RS - Serbia 3
TH - Thailandia 3
UY - Uruguay 3
UZ - Uzbekistan 3
YE - Yemen 3
BB - Barbados 2
CY - Cipro 2
EU - Europa 2
GP - Guadalupe 2
HU - Ungheria 2
KH - Cambogia 2
LB - Libano 2
LY - Libia 2
RO - Romania 2
SN - Senegal 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
Totale 17.620
Città #
Singapore 1.266
San Jose 853
Chandler 708
Ashburn 605
Jacksonville 573
Dublin 531
Izmir 343
Beijing 307
Dallas 273
Chieti 255
Dearborn 253
Council Bluffs 232
Southend 226
Princeton 215
Los Angeles 174
Nanjing 167
Santa Clara 163
The Dalles 163
Ann Arbor 151
Ho Chi Minh City 134
Wilmington 120
Cambridge 117
New York 103
Kraków 98
Hanoi 85
Washington 82
Buffalo 77
Nanchang 77
Tongling 68
Altamura 64
Hong Kong 61
Houston 60
Woodbridge 57
São Paulo 52
North Bergen 51
Boardman 50
Munich 49
Pescara 48
Moscow 47
Rome 44
Hefei 40
Phoenix 40
Columbus 39
Hebei 39
Kunming 39
Orem 39
Tokyo 39
Atlanta 38
Kocaeli 38
Milan 38
Warsaw 38
Shenyang 36
Tianjin 36
Brooklyn 35
Toronto 34
Denver 33
Helsinki 33
Montreal 33
Jiaxing 32
Teramo 32
Bologna 31
Redondo Beach 31
Bosa 30
London 30
Jinan 29
Changsha 28
Dong Ket 28
Ottawa 26
Brussels 25
Chicago 25
Vienna 24
Poplar 23
Stockholm 23
Brno 22
Chennai 22
Vilnius 21
Haiphong 20
League City 20
Seoul 20
Da Nang 19
Nuremberg 19
Frankfurt am Main 18
Ningbo 18
Norwalk 18
Augusta 17
Mexico City 17
Turku 17
Johannesburg 16
Seattle 16
Agrolândia 15
Amsterdam 15
Ankara 15
Hangzhou 15
Como 14
Mount Pleasant 14
Naples 14
San Francisco 14
Mumbai 13
Rio de Janeiro 13
San Mateo 13
Totale 10.541
Nome #
Effects of PPARα inhibition in head and neck paraganglioma cells 220
Inhibition of PPARγ by Natural Compounds as a Promising Strategy in Obesity and Diabetes 207
Anticancer Activity of Stilbene-Based Derivatives 206
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 205
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 204
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 197
Synthesis of fibrates analogues and pharmacological evaluation as PPARa agonists 195
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 190
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 188
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 188
2-Substituted Benzothiazoles as Antiproliferative Agents: Novel Insights on Structure-Activity Relationships 187
Sintesi di nuovi derivati dell'anello 2-ossazolidinonico: molecole di notevole interesse come ausiliari chirali e come potenziali agenti antimicrobici 186
Progettazione e sintesi di ossazolidinoni a potenziale attività antibatterica 185
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 183
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 183
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 183
Asymmetric synthesis of (S)-ibuprofen by esterification with amides of (S)-lactic acid as chiral auxiliaries: experimental and theoretical results 182
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 179
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 178
Anti-Inflammatory, Antioxidant, and WAT/BAT-Conversion Stimulation Induced by Novel PPAR Ligands: Results from Ex Vivo and In Vitro Studies 176
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 176
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 175
Synthesis and antiplatelet activity of gemfibrozil chiral analogues 172
Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview 172
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 171
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 170
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 170
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 169
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 169
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 167
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 166
Asymmetric synthesis of enantiomerically enriched chiral fibrates, thiols and aminoacids 165
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 165
Sintesi ed attività antibatterica di 3-cinnamoil e 3-piridinilossazolidin -2-oni 163
Embedding calix[4]resorcinarenes in liposomes: Experimental and computational investigation of the effect of resorcinarene inclusion on liposome properties and stability 163
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 162
Development of a Rapid Mass Spectrometric Determination of AMP and Cyclic AMP for PDE3 Activity Study: Application and Computational Analysis for Evaluating the Effect of a Novel 2-oxo-1,2-dihydropyridine-3-carbonitrile Derivative as PDE-3 Inhibitor 162
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 161
Synthesis of diastereomerically enriched 2-bromoesters and their reaction with nucleophiles 160
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 157
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 155
N-acylsulfonamides: synthetic routes and biological potential in medicinal chemistry 155
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 154
Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid 154
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 153
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 153
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 152
Synthesis and antiplatelet activity of clofibric acid analogues 150
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 150
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 150
Antiplatelet activity of gemfibrozil chiral analogues 149
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 148
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 147
Synthetic Strategies to Serine-Proline Chimeras: An Overview 147
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 146
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 146
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 145
The anticancer potential of Peroxisome Proliferator-Activated Receptor antagonists 144
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 143
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 143
Sintesi di analoghi chirali del gemfibrozil 2,5,disostituiti a potenziale attività antiaggregante piastrinica 142
Structural development studies of PPARs ligands based on tyrosine scaffold 142
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 142
Seeking for Non-Zinc-Binding MMP-2 Inhibitors: Synthesis, Biological Evaluation and Molecular Modelling Studies 141
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 140
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 140
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 139
Optically active 2-substituted carboxylic acids isosters of fibrates by 2-bromo esters 138
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 137
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 136
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 135
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 135
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 134
Development of Fibrates as Important Scaffolds in Medicinal Chemistry 134
CAPE derivatives: Multifaceted agents for chronic wound healing 132
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 131
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 131
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 129
Effects of phosphonate isosters of clofibric acid on the biophysical and pharmacological properties of chloride channels belonging to the CLC superfamily 129
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 129
Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry 128
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 128
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 128
null 128
A Review of Strategies for the Development of Alkyl Prolines in Drug Discovery 128
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 128
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 126
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 124
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 124
Synthesis, biological evaluation and molecular modelling of new PPARa agonists 122
Effect of milrinone analogues on intracellular calcium increase on single living H9C2 cells 122
Phenylsulfonimide PPARα Antagonists Enhance Nrf2 Activation and Promote Oxidative Stress-Induced Apoptosis/Pyroptosis in MCF7 Breast Cancer Cells 121
Sintesi asimetrica e determinazione della configurazione assoluta di analoghi chirali solforati del clofibrato 121
Methods to Evaluate the Activity of Nitric Oxide Synthase 121
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 121
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 121
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 120
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 120
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 120
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 119
Totale 15.327
Categoria #
all - tutte 68.705
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.705


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022567 0 0 0 0 59 15 27 61 105 26 90 184
2022/20231.981 145 269 135 202 191 373 92 169 254 24 72 55
2023/2024949 67 35 75 32 61 291 216 13 6 42 8 103
2024/20252.322 87 401 375 61 51 119 88 152 208 124 326 330
2025/20265.341 437 207 489 708 623 312 935 341 517 426 266 80
2026/20271.605 155 230 287 705 228 0 0 0 0 0 0 0
Totale 18.341